JP2011513304A5 - - Google Patents

Download PDF

Info

Publication number
JP2011513304A5
JP2011513304A5 JP2010548648A JP2010548648A JP2011513304A5 JP 2011513304 A5 JP2011513304 A5 JP 2011513304A5 JP 2010548648 A JP2010548648 A JP 2010548648A JP 2010548648 A JP2010548648 A JP 2010548648A JP 2011513304 A5 JP2011513304 A5 JP 2011513304A5
Authority
JP
Japan
Prior art keywords
composition
rosacea
item
dapsone
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010548648A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011513304A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/002549 external-priority patent/WO2009108147A1/en
Publication of JP2011513304A publication Critical patent/JP2011513304A/ja
Publication of JP2011513304A5 publication Critical patent/JP2011513304A5/ja
Pending legal-status Critical Current

Links

JP2010548648A 2008-02-27 2008-02-27 酒さを処置するためのダプソン Pending JP2011513304A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2008/002549 WO2009108147A1 (en) 2008-02-27 2008-02-27 Dapsone to treat rosascea

Publications (2)

Publication Number Publication Date
JP2011513304A JP2011513304A (ja) 2011-04-28
JP2011513304A5 true JP2011513304A5 (https=) 2011-06-16

Family

ID=41016365

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010548648A Pending JP2011513304A (ja) 2008-02-27 2008-02-27 酒さを処置するためのダプソン

Country Status (8)

Country Link
US (3) US8586010B2 (https=)
EP (1) EP2249765B1 (https=)
JP (1) JP2011513304A (https=)
AU (1) AU2008351422A1 (https=)
BR (1) BRPI0822264A2 (https=)
CA (1) CA2714674A1 (https=)
ES (1) ES2775825T3 (https=)
WO (1) WO2009108147A1 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110152379A1 (en) * 2008-07-25 2011-06-23 Sang Chul Park Composition for control of aging and/or extension of life, containing dapsone as active ingredient
MX2009004635A (es) * 2009-04-29 2010-10-29 Univ Autonoma Metropolitana Formas farmaceúticas solubles de la n,n´-diamino-difenilsulfona para su uso óptimo en el tratamiento de diversas enfermedades.
KR101924162B1 (ko) * 2010-03-15 2018-11-30 버지니아 커먼웰스 유니버시티 기도의 염증 및 이상성 점액섬모 전달의 치료법으로서의 에어로졸화 댑손
KR101875705B1 (ko) 2011-12-07 2018-07-06 삼성전자주식회사 디아미노디페닐술폰을 포함하는 근육 소모 관련 질환의 예방 또는 치료용 약학적 조성물
US20130255699A1 (en) 2012-04-02 2013-10-03 TurnCare, Inc. Patient-orienting alternating pressure decubitus prevention support apparatus
US11039962B2 (en) 2012-04-02 2021-06-22 TurnCare, Inc. Non-invasive pressure-mitigation apparatuses for improving blood flow and associated systems and methods
DK2922528T3 (en) * 2012-11-20 2017-09-18 Allergan Inc TOPICAL DAPSON AND DAPSON / ADAPALEN COMPOSITIONS AND PROCEDURES FOR USE THEREOF
US12178949B2 (en) 2020-10-09 2024-12-31 TurnCare, Inc. Pressure-mitigation apparatuses for improved treatment of immobilized patients and associated systems and methods
US12016812B2 (en) 2020-10-09 2024-06-25 TurnCare, Inc. Pressure-mitigation apparatuses for improved treatment of respiratory illnesses and associated systems and methods
JPWO2022269665A1 (https=) * 2021-06-21 2022-12-29

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3419009A1 (de) 1984-05-22 1985-11-28 Dr. Karl Thomae Gmbh, 7950 Biberach Neue substituierte bis(4-aminophenyl)sulfone, ihre herstellung und ihre verwendung als arzneimittel
DE3603577A1 (de) 1986-02-06 1987-08-13 Joachim K Prof Dr Seydel Neue substituierte 2,4-diamino-5-benzylpyrimidine, deren herstellung und deren verwendung als arzneimittel mit antibakterieller wirksamkeit
US5733572A (en) 1989-12-22 1998-03-31 Imarx Pharmaceutical Corp. Gas and gaseous precursor filled microspheres as topical and subcutaneous delivery vehicles
US20030157036A1 (en) * 2002-02-20 2003-08-21 Osborne David W. Topical dapsone for the treatment of acne
US5863560A (en) 1996-09-11 1999-01-26 Virotex Corporation Compositions and methods for topical application of therapeutic agents
US6056954A (en) 1997-10-31 2000-05-02 New Horizons Diagnostics Corp Use of bacterial phage associated lysing enzymers for the prophylactic and therapeutic treatment of various illnesses
US6277399B1 (en) 1997-10-31 2001-08-21 New Horizon Diagnostics Corporation Composition incorporating bacterial phage associated lysing enzymes for treating dermatological infections
US6248324B1 (en) 1997-10-31 2001-06-19 Vincent Fischetti Bacterial phage associated lysing enzymes for treating dermatological infections
US6254866B1 (en) 1997-10-31 2001-07-03 New Horizons Diagnostics Corporation Use of phage associated lytic enzymes for treating bacterial infections of the digestive tract
US6056955A (en) 1999-09-14 2000-05-02 Fischetti; Vincent Topical treatment of streptococcal infections
US6989156B2 (en) * 2001-04-23 2006-01-24 Nucryst Pharmaceuticals Corp. Therapeutic treatments using the direct application of antimicrobial metal compositions
US20060204526A1 (en) * 2003-08-13 2006-09-14 Lathrop Robert W Emulsive composition containing Dapsone
MXPA06001713A (es) * 2003-08-13 2007-01-26 Qlt Usa Inc Composicion de emulsion que contiene dapsone.
FR2866570B1 (fr) * 2004-02-20 2007-08-24 Galderma Res & Dev Utilisation du metronidazole pour la preparation d'une composition pharmaceutique destinee a traiter une inflammation cutanee
WO2007002447A2 (en) * 2005-06-23 2007-01-04 Bioform Medical, Inc. Compositions for treating rosacea
EP2620145A3 (en) * 2006-08-16 2014-01-08 Action Medicines, S.L. 2,5-dihydroxybenzene compounds for the treatment of of cancer of an organ

Similar Documents

Publication Publication Date Title
JP2011513304A5 (https=)
JP5882260B2 (ja) ペプチドおよびその使用
BRPI0414581C1 (pt) composto, composição farmacêutica compreendendo o referido composto e uso do referido composto
JP2009544722A5 (https=)
CN115697994A (zh) 稠合喹唑啉类衍生物、其制备方法及其在医药上的应用
WO2006076620A3 (en) Bendamustine pharmaceutical compositions for lyophilisation
JP2008533007A5 (https=)
CL2012001056A1 (es) Compuestos derivados de cromenona sustituidos, inhibidores de enzimas pi 3 quinasa; composicion farmaceutica; y uso en el tratamiento o prevencion de trastornos de proliferacion celular, tales como tumores enfermedades inflamatorias y fibroticas, asma, diabetes insulinodependiente, entre otras.
EP2143446A4 (en) HYBRID GEL WITH CHEMICALLY NETWORKED HYALURONIC ACID DERIVATIVE AND MEDICAMENT THEREFOR
GT200600096A (es) Composicion farmaceutica para el tratamiento del cancer
CA2672452A1 (en) Tannate salt of rasagiline
AR079706A1 (es) Composiciones, metodos para el tratamiento de enfermedades oculares relacionadas con la angiogenesis y uso
JP2012521351A5 (https=)
WO2006101858B1 (en) Alpha-helix mimetics and methods relating to the treatment of fibrosis
WO2009109654A3 (en) 1-benzyl-3-hydr0xymethylindaz0le derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cxcr1 and p40
CN101972225A (zh) 一种含吡非尼酮的凝胶组合物
Badavath et al. Design, in-silico docking and predictive ADME properties of novel pyrazoline derivatives with selective human MAO inhibitory activity
JP2022028975A5 (https=)
EA201270653A1 (ru) Антагонист dpи его применение
WO2007121545A8 (en) S-nitrosothiols containing compositions for the treatment of fatty liver diseases, obesity and other diseases associated with the metabolic syndrome and the use of such compositions
RU2007129571A (ru) Композиции на основе солей гиалуроновой кислоты для лечения эпителиальных повреждений
WO2007019078A3 (en) Tricyclic beta-secretase inhibitors for the treatment of alzheimer's disease
JP2023006351A (ja) 抗ウイルス用組成物
CN105687173A (zh) 乳酸和/或其盐在制备单胺氧化酶抑制剂中的用途
WO2007042983A3 (en) Fluridone as an anti-inflammatory agent